Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mBPaL trial for Pre-XDR/MDR TB
NCT05040126Phase 3Active, not recruiting
- Sponsor
- National Institute for Research in Tuberculosis
- Start
- Oct 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of linezolid in pulmonary tuberculosis (TB), sponsored by National Institute for Research in Tuberculosis. Started Oct 2021; status: active, not recruiting.
02
Drugs
linezolid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT05040126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05040126.